Debut Plus

₹23.67

▼ -0.16 -0.67%

18 Jul 2026

NSE Listed · Pharmaceuticals

ESM 1

Balaxi Pharma Ltd. (BALAXI)

Volume: 49,128Avg Vol 1W: 25,611Avg Vol 1M: 25,18752W Range:₹15.2₹52.5
NSE BSE www.balaxipharma.in
Key Ratios
Checked just now
Market Cap₹131 Cr
Current Price₹23.67
Previous Close₹23.83
High / Low (52w)₹52.5 / ₹15.2
Volume49,128
Avg Vol (1W)25,611
Avg Vol (1M)25,187
Stock P/E215.18
Book Value₹45.12
Dividend Yield0%
ROE56.89%
ROA42.13%
Revenue (TTM)—
Revenue Growth21.25%
Profit Margin52.56%
Total Debt₹21 Cr
Shares Outstanding6 Cr
Face Value₹2
EPS (TTM)₹0.26
P/B0.52
Debt / Equity0.17
50 DMA₹24.54
200 DMA₹28.16
Day change-0.67%
SurveillanceESM 1 (as of 2026-07-18)
Price Chart
₹23.67▼ 51.70% · 1Y
₹68₹1618.5L
2025-07-18
2026-07-17

20-day avg volume: 27K shares

Pros
  • Healthy return on equity of 56.9%.
  • Company is almost debt-free.
  • Revenue grew 22% YoY.
  • Stock trades below its book value.
Cons
  • Stock trades at a high P/E of 215.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹66 Cr₹77 Cr₹73 Cr₹76 Cr₹71 Cr₹56 Cr₹73 Cr₹71 Cr
EBITDA₹8 Cr₹6 Cr₹7 Cr₹10 Cr₹2 Cr₹2 Cr₹3 Cr₹2 Cr
Net Profit₹6 Cr₹5 Cr₹5 Cr₹9 Cr₹0 Cr₹0 Cr₹0 Cr₹1 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹14 Cr₹46 Cr₹234 Cr₹284 Cr₹339 Cr₹242 Cr₹295 Cr
EBITDA₹2 Cr₹9 Cr₹44 Cr₹55 Cr₹57 Cr₹42 Cr₹32 Cr
Net Profit₹2 Cr₹6 Cr₹38 Cr₹48 Cr₹46 Cr₹-2 Cr₹25 Cr
EPS6.478.1238.1447.6645.4-0.464.54
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹6 Cr₹36 Cr₹100 Cr₹176 Cr₹240 Cr₹258 Cr₹310 Cr
Total Liabilities₹3 Cr₹8 Cr₹35 Cr₹63 Cr₹57 Cr₹57 Cr₹79 Cr
Equity₹4 Cr₹28 Cr₹65 Cr₹113 Cr₹183 Cr₹201 Cr₹232 Cr
Total Debt———————
Cash Flow
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹-1 Cr₹-13 Cr₹3 Cr₹40 Cr₹18 Cr₹12 Cr₹-32 Cr
Investing₹0 Cr₹0 Cr₹-6 Cr₹-28 Cr₹-11 Cr₹-1 Cr₹-22 Cr
Financing₹0 Cr₹18 Cr₹4 Cr₹0 Cr₹26 Cr₹30 Cr₹34 Cr
Free Cash Flow₹-1 Cr₹-13 Cr₹3 Cr₹40 Cr₹16 Cr₹12 Cr₹-32 Cr
Shareholding
Promoter 65.99% Institutions 2.56% Public 31.45%
Efficiency & Working Capital
ROCE3%
Interest Coverage8.2
Dividend Payout—
Debtor Days138 d
Inventory Days98 d
Payable Days20 d
Cash Conversion Cycle216 d
Working Capital Days236 d
Shareholding Details

As of 2026-03-31

Promoter66%
FII0%
DII2.6%
Institutions2.6%
Public31.4%
Promoter Pledge0%
No. of Shareholders15,176
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodDec 2023Mar 2024Apr 2024Apr 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Promoters71.2%66.4%66.4%66.4%66%66%66%66%66%66%66%66%
FIIs18.6%17.1%17.1%17.1%16.9%16.5%16.5%16%8.9%3.5%1.7%0%
DIIs0%0%0%0%0%0%0%0%0%0%0%2.6%
Public10.2%16.5%16.5%16.5%17.1%17.5%17.5%18%25.1%30.5%32.2%31.4%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders5,0455,1325,1325,1326,5867,8638,5299,99413,73714,62015,08515,176
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Balaxi Overseas Private LimitedShareholding of Promoter and Promoter Group63.4%3.50 Cr
Rgsl Investment Fund - Rgsl Investment Lvf 1Public Shareholding2.5%14,00,537
Kunal Mahendra BhaktaPublic Shareholding1.9%10,28,855
Ashish MaheshwariShareholding of Promoter and Promoter Group1.6%9,03,870
Amol Anand MantriPublic Shareholding1.4%7,78,176
P P Zibi BosePublic Shareholding1.3%7,10,821
Minoshi MaheshwariShareholding of Promoter and Promoter Group1%5,27,900
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Minoshi Maheshwari00%2026-03-31
Ashish Maheshwari00%2026-03-31
Balaxi Overseas Private Limited00%2026-03-31
Rgsl Investment Fund - Rgsl Investment Lvf 100%2026-03-31
Amol Anand Mantri00%2026-03-31
P P Zibi Bose00%2026-03-31
Kunal Mahendra Bhakta00%2026-03-31
Minoshi Maheshwari00%2025-12-31
Ashish Maheshwari00%2025-12-31
Balaxi Overseas Private Limited00%2025-12-31
Nexpact Limited00%2025-12-31
Amol Anand Mantri00%2025-12-31
Board of Directors
NameDesignationYear
Ashish MaheshwariManaging Director2024
Minoshi MaheshwariNon Executive Director2024
Kunal M BhaktaIndependent Non Exe. Director2024
Gandhi GamjiIndependent Non Exe. Director2024
M. Srinivas RaoIndependent Non Exe. Director2024
Mohith Kumar KhandelwalCompany Sec. & Compli. Officer2024
Segments — Product
SegmentRevenueShare
Specialized Wholesale₹0 Cr—
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹2401111
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202561002063
2025000202
202561000061
Company Information
Incorporated1942
AuditorP Murali & Co
Investor Email[email protected]
🌐 www.balaxipharma.in ↗

📍 41/298-D2 2nd Flr Saniya Plaza, Mahakavi Bharatiyar Road, Cochin, Kerala, 682035

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Bajel Projects LimitedBajaj Finance LimitedShree Tirupati Balajee LimitedBalaji Phosphates LimitedBalaji Telefilms Limited.Balaji Amines LimitedSolve Plastic Products LimitedBalkrishna Paper Mills LimitedBalkrishna Ind. Ltd.Balmer Lawrie & Co Ltd.Bal Pharma Ltd.Balrampur Chini Mills Ltd.All “B” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search